Regeneron: PCSK9s Drowning In Paperwork
But almost 75% of commercially insured patients and 91% of Medicare patients have access to Praluent, the firm reported.
But almost 75% of commercially insured patients and 91% of Medicare patients have access to Praluent, the firm reported.